HSBC Holdings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-20,000
| Closed | -$2.46M | – | 3042 |
|
|
2025
Q4 | $2.46M | Sell |
20,000
-56,700
| -74% | -$6.89M | ﹤0.01% | 1483 |
|
|
2025
Q3 | $8.58M | Buy |
76,700
+50,700
| +195% | +$5.76M | ﹤0.01% | 988 |
|
|
2025
Q2 | $2.88M | Sell |
26,000
-600
| -2% | -$63.9K | ﹤0.01% | 1347 |
|
|
2025
Q1 | $2.95M | Buy |
26,600
+9,000
| +51% | +$929K | ﹤0.01% | 1300 |
|
|
2024
Q4 | $1.62M | Buy |
+17,600
| New | +$1.58M | ﹤0.01% | 1562 |
|
|
2024
Q3 | – | Sell |
-129,700
| Closed | -$8.93M | – | 3044 |
|
|
2024
Q2 | $8.93M | Sell |
129,700
-60,000
| -32% | -$4M | 0.01% | 898 |
|
|
2024
Q1 | $13.9M | Buy |
189,700
+110,700
| +140% | +$8.51M | 0.01% | 788 |
|
|
2023
Q4 | $6.4M | Sell |
79,000
-82,100
| -51% | -$6.39M | 0.01% | 1063 |
|
|
2023
Q3 | $12.1M | Buy |
161,100
+63,800
| +66% | +$4.91M | 0.01% | 769 |
|
|
2023
Q2 | $7.43M | Sell |
97,300
-206,300
| -68% | -$16.5M | 0.01% | 911 |
|
|
2023
Q1 | $24.8M | Sell |
303,600
-329,900
| -52% | -$27.3M | 0.03% | 546 |
|
|
2022
Q4 | $54.2M | Buy |
633,500
+333,300
| +111% | +$26.4M | 0.06% | 327 |
|
|
2022
Q3 | $18.7M | Buy |
300,200
+157,400
| +110% | +$9.93M | 0.03% | 576 |
|
|
2022
Q2 | $8.89M | Sell |
142,800
-160,000
| -53% | -$9.91M | 0.01% | 960 |
|
|
2022
Q1 | $18M | Sell |
302,800
-91,000
| -23% | -$5.82M | 0.02% | 637 |
|
|
2021
Q4 | $28.6M | Buy |
393,800
+250,100
| +174% | +$17.2M | 0.03% | 569 |
|
|
2021
Q3 | $10.1M | Buy |
143,700
+58,000
| +68% | +$4.07M | 0.01% | 875 |
|
|
2021
Q2 | $5.89M | Buy |
85,700
+43,700
| +104% | +$2.92M | 0.01% | 1051 |
|
|
2021
Q1 | $2.71M | Sell |
42,000
-51,500
| -55% | -$3.32M | ﹤0.01% | 1213 |
|
|
2020
Q4 | $5.45M | Buy |
93,500
+4,500
| +5% | +$272K | 0.01% | 988 |
|
|
2020
Q3 | $5.62M | Sell |
89,000
-6,900
| -7% | -$478K | 0.01% | 914 |
|
|
2020
Q2 | $7.38M | Buy |
95,900
+22,200
| +30% | +$1.7M | 0.01% | 727 |
|
|
2020
Q1 | $5.51M | Sell |
73,700
-144,200
| -66% | -$9.96M | 0.01% | 797 |
|
|
2019
Q4 | $14.2M | Sell |
217,900
-102,500
| -32% | -$6.67M | 0.02% | 667 |
|
|
2019
Q3 | $20.3M | Buy |
320,400
+75,700
| +31% | +$4.95M | 0.04% | 529 |
|
|
2019
Q2 | $16.5M | Buy |
244,700
+4,700
| +2% | +$309K | 0.03% | 589 |
|
|
2019
Q1 | $15.6M | Sell |
240,000
-226,900
| -49% | -$15.1M | 0.03% | 588 |
|
|
2018
Q4 | $29.2M | Buy |
466,900
+103,200
| +28% | +$7.21M | 0.05% | 364 |
|
|
2018
Q3 | $28.1M | Buy |
363,700
+93,100
| +34% | +$7.03M | 0.05% | 420 |
|
|
2018
Q2 | $19.2M | Sell |
270,600
-182,000
| -40% | -$12.9M | 0.03% | 513 |
|
|
2018
Q1 | $34M | Buy |
452,600
+286,600
| +173% | +$22.8M | 0.05% | 358 |
|
|
2017
Q4 | $11.9M | Sell |
166,000
-427,400
| -72% | -$32.5M | 0.02% | 627 |
|
|
2017
Q3 | $48.1M | Sell |
593,400
-175,300
| -23% | -$13.4M | 0.08% | 243 |
|
|
2017
Q2 | $54.4M | Buy |
768,700
+131,300
| +21% | +$8.74M | 0.1% | 184 |
|
|
2017
Q1 | $43.4M | Buy |
637,400
+186,800
| +41% | +$13.1M | 0.09% | 214 |
|
|
2016
Q4 | $32.3M | Buy |
450,600
+275,800
| +158% | +$20.5M | 0.08% | 303 |
|
|
2016
Q3 | $13.8M | Buy |
174,800
+95,000
| +119% | +$7.72M | 0.03% | 553 |
|
|
2016
Q2 | $6.66M | Sell |
79,800
-259,100
| -76% | -$23M | 0.02% | 814 |
|
|
2016
Q1 | $31.1M | Buy |
338,900
+262,500
| +344% | +$23.7M | 0.09% | 271 |
|
|
2015
Q4 | $7.78M | Buy |
76,400
+41,300
| +118% | +$4.3M | 0.02% | 781 |
|
|
2015
Q3 | $3.45M | Buy |
+35,100
| New | +$3.9M | 0.01% | 921 |
|
|
2015
Q2 | – | Sell |
-23,600
| Closed | -$2.32M | – | 2156 |
|
|
2015
Q1 | $2.32M | Sell |
23,600
-94,800
| -80% | -$9.63M | ﹤0.01% | 1137 |
|
|
2014
Q4 | $11.2M | Buy |
118,400
+65,000
| +122% | +$6.72M | 0.02% | 628 |
|
|
2014
Q3 | $5.68M | Buy |
53,400
+45,100
| +543% | +$4.42M | 0.01% | 830 |
|
|
2014
Q2 | $689K | Buy |
8,300
+100
| +1% | +$7.78K | ﹤0.01% | 1392 |
|
|
2014
Q1 | $581K | Buy |
8,200
+2,200
| +37% | +$173K | ﹤0.01% | 1363 |
|
|
2013
Q4 | $451K | Buy |
6,000
+5,000
| +500% | +$348K | ﹤0.01% | 1456 |
|
|
2013
Q3 | $63K | Buy |
+1,000
| New | +$59.8K | ﹤0.01% | 1630 |
|
Other funds holding GILD
VCM
VPM
HSBC Holdings's GILD Position: Q1 2026 in Review
HSBC Holdings reduced its Gilead Sciences (GILD) stake by 15% in Q1 2026, selling an estimated $81.9M and leaving 3,190,339 shares worth $444M. The position accounts for 0.23% of the portfolio, ranked #76.
HSBC Holdings first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $464M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- HSBC Holdings held 3,190,339 shares of Gilead Sciences worth $444M as of Q1 2026.
- HSBC Holdings sold 584,817 Gilead Sciences shares in Q1 2026, an estimated $81.9M.
- Gilead Sciences made up 0.23% of HSBC Holdings's portfolio in Q1 2026, its #76 holding.
- HSBC Holdings first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Gilead Sciences position peaked at $464M in Q4 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.